Can I increase the dose of trazodone to 300 mg for insomnia?

Should You Increase Trazodone to 300mg for Sleep?

No, you should not increase trazodone to 300mg for insomnia—current clinical practice guidelines explicitly advise against using trazodone for chronic insomnia disorder, and the evidence shows it provides minimal benefit while carrying significant risks. 1

Guideline Recommendations

The 2019 VA/DoD Clinical Practice Guidelines for chronic insomnia disorder specifically recommend against using trazodone for treatment of insomnia 1. This recommendation is based on systematic reviews showing:

• No difference in sleep efficiency between trazodone (50-150mg) and placebo
• No differences in sleep onset latency, total sleep time, or wake after sleep onset
• Only subjective sleep quality showed improvement, but this was outweighed by adverse effects
• Studies were very short duration (mean 1.7 weeks) with limited follow-up 1

FDA-Approved Dosing Context

The FDA label for trazodone indicates it is approved only for depression, not insomnia 2. For depression:

• Initial dose: 150mg/day in divided doses
• Maximum outpatient dose: 400mg/day
• Doses of 150-300mg show antidepressant effects 3, 4

Critical point: At 300mg, you're using a full antidepressant dose, not a hypnotic dose. Low-dose trazodone (25-100mg) is what's typically used off-label for sleep 5, 4.

Safety Concerns at Higher Doses

Increasing to 300mg significantly increases risks:

• Orthostatic hypotension and syncope 2
• Cardiac arrhythmias, especially with QT prolongation 2
• Priapism (medical emergency requiring immediate discontinuation) 2
• Next-morning impairment affecting driving and cognitive function 2
• Serotonin syndrome risk, particularly with other serotonergic medications 2
• Increased bleeding risk with anticoagulants/antiplatelets 2

What the Evidence Actually Shows

Recent meta-analyses reveal trazodone's limited efficacy for insomnia:

• Does not significantly increase subjective total sleep time 6
• Improves sleep quality scores but with high dropout rates due to adverse effects (RR=2.30) 6
• More adverse effects overall (RR=1.18) and specifically sleep-related adverse effects (RR=4.31) 6
• Objective polysomnography shows only 28 minutes increase in total sleep time 6

Recommended Alternatives

Instead of escalating trazodone, consider:

1. First-line: Cognitive Behavioral Therapy for Insomnia (CBT-I) - most effective long-term treatment 7

2. If pharmacotherapy needed:

   • Low-dose doxepin (3-6mg) - has better evidence for insomnia 1
   • Nonbenzodiazepine BZRAs (zolpidem, eszopiclone) at lowest effective dose for shortest duration 1
   • Use these only short-term with clear discontinuation plan

3. If already on trazodone:

   • Consider tapering off gradually rather than increasing 2
   • Reassess for underlying causes: depression, sleep apnea, restless legs, medication effects
   • Screen for comorbid psychiatric conditions requiring different treatment

Clinical Pitfalls to Avoid

• Don't confuse sedation with therapeutic sleep improvement - trazodone causes drowsiness but doesn't normalize sleep architecture effectively
• Don't use 300mg doses for insomnia alone - this is an antidepressant dose with full adverse effect profile
• Don't ignore tolerance development - evidence suggests tolerance occurs with continued use 8
• Don't overlook drug interactions - at 300mg, CYP3A4 interactions become more significant 2

Bottom line: Increasing trazodone to 300mg for insomnia contradicts current guidelines, lacks supporting evidence, and substantially increases harm risk. Reassess the diagnosis and consider evidence-based alternatives.